James Rotolo Medical is categorized under Accountants in Manasquan, NJ and active since 2006.
James Rotolo Medical was established in 2006, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Accountants business, which does work in the B2B market, and is classified as a Accountants, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Jeri Seekford, Office Manager at the company’s single location by writing to 2401 Highway 35, Manasquan, New Jersey NJ 08736 or by phoning (732) 223-7877. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | James Rotolo Medical |
| Contact Person: | Jeri Seekford, Office Manager |
| Address: | 2401 Highway 35, Manasquan, New Jersey 08736 |
| Phone Number: | (732) 223-7877 |
| Website Address: | newjerseyurologists.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Accountants |
| SIC Code: | 8721 |
| NAICS Code: | 6211110 |
| Share This Business: |
James Rotolo Medical was started in 2006 to provide professional Accountants under the SIC code 8721 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Jeri Seekford, Office Manager for inquiries that concern James Rotolo Medical by calling the company number (732) 223-7877, as your correspondence is most welcome. Additionally, the physical location of the single location of James Rotolo Medical can be found at the coordinates 40.12757,-74.06762 as well as the street address 2401 Highway 35 in Manasquan, New Jersey 08736.
For its online presence, you may visit James Rotolo Medical’s website at newjerseyurologists.com and engage with its social media outlets through on Twitter and on Facebook.